Erectile Dysfunction Pipeline Review and Therapeutic Products under Development, H2 2015

Erectile Dysfunction - Pipeline Review, H2 2015 Provides an overview of the Erectile Dysfunction's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects.

Companies Mentioned in report are Late Stage Products, Clinical Stage Products, Early Stage Products, Unknown Stage Products

Get a copy of this report at . This is a premium report price at US$2000 for a single user PDF license

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.


- The report provides a snapshot of the global therapeutic landscape of Erectile Dysfunction

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Erectile Dysfunction and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Erectile Dysfunction products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.